webinar register page

AHNS Virtual Education Series: Indications of PD-1 Inhibitors for Advanced cSCC
April 14, 2021

The webinar will review the current data supporting the approvals for immune checkpoint inhibitors. Cases will be utilized to highlight the direct clinical application.

Learning Objective:

At the conclusion of the activity, participants will be able to:
Define the current approved indications for immune checkpoint inhibitors.


Kevin Emerick, MD, Massachusetts Eye & Ear Infirmary


Gina Jefferson, MD, MS, The University of Mississippi Medical Center

Miriam Lango, MD, MD Anderson Cancer Center

David Miller, MD, PhD, Massachusetts General Cancer Center

Matthew Witek, MD, MS, University of Maryland School of Medicine

Apr 14, 2021 04:00 PM in Pacific Time (US and Canada)

* Required information

By registering, I agree to the Privacy Statement and Terms of Service.